• LAST PRICE
    1.9000
  • TODAY'S CHANGE (%)
    Trending Down-0.1400 (-6.8627%)
  • Bid / Lots
    1.9200/ 1
  • Ask / Lots
    2.0800/ 1
  • Open / Previous Close
    2.0300 / 2.0400
  • Day Range
    Low 1.8700
    High 2.0400
  • 52 Week Range
    Low 1.6200
    High 5.7000
  • Volume
    224,800
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.04
TimeVolumeVOR
09:32 ET10062.04
09:36 ET5002.0249
09:38 ET3002.02
09:39 ET9952.0238
09:41 ET55042.005
09:43 ET1001.99
09:45 ET38002
09:48 ET1002.01
09:50 ET1002
09:54 ET3801.995
09:56 ET3202
09:57 ET2461.9994
10:01 ET1001.99
10:10 ET30001.975
10:12 ET2511.9795
10:15 ET11001.97
10:17 ET2501.98
10:19 ET1001.98
10:24 ET1001.97
10:26 ET1001.97
10:30 ET11151.97
10:35 ET1321.9694
10:37 ET47701.979
10:42 ET1001.98
10:55 ET106281.9762
11:04 ET7941.9993
11:15 ET1002
11:22 ET1001.98
11:26 ET2011.98
11:31 ET2001.9899
11:38 ET3471.98
11:45 ET2001.985
11:47 ET3141.98
11:49 ET361951.945
11:54 ET2501.96
12:03 ET5991.94
12:16 ET6001.93
12:25 ET4911.9299
12:30 ET10661.9212
12:32 ET1011.92
12:36 ET1001.92
12:41 ET4001.92
12:45 ET2001.93
12:50 ET6001.9299
12:56 ET25971.92
12:57 ET6641.915
12:59 ET15871.93
01:10 ET40001.9316
01:12 ET151051.9
01:15 ET2501.9001
01:17 ET4361.909
01:21 ET2001.9091
01:32 ET5001.9061
01:33 ET8911.9073
01:37 ET80591.87
01:39 ET10001.875
01:42 ET18781.87
01:44 ET2451.8784
01:48 ET5841.875
01:50 ET12141.8995
01:51 ET7501.895
01:55 ET22261.8999
02:02 ET1001.895
02:06 ET5071.8903
02:08 ET1001.89
02:09 ET1001.895
02:15 ET10001.898
02:24 ET62961.9081
02:26 ET23741.91
02:29 ET1321.91
02:31 ET17681.9
02:33 ET4391.9
02:40 ET16991.9
02:42 ET3161.896
02:45 ET6001.89
02:49 ET1611.8902
02:51 ET11991.9
02:56 ET12631.9085
03:02 ET5001.9
03:03 ET16501.9095
03:07 ET1051.9092
03:09 ET21001.9
03:14 ET1001.9
03:18 ET3001.9
03:20 ET7001.9011
03:21 ET1001.9
03:23 ET1001.9089
03:25 ET3001.9
03:27 ET1001.9
03:30 ET2001.9
03:32 ET16971.9
03:34 ET1001.905
03:36 ET1001.9
03:39 ET1001.9
03:41 ET40901.92
03:43 ET4601.9199
03:45 ET2381.9118
03:48 ET15041.9299
03:50 ET1041.9291
03:52 ET27781.92
03:54 ET26301.9
03:56 ET23681.91
03:57 ET13001.9
03:59 ET195941.9
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVOR
Vor Biopharma Inc
129.5M
-1.1x
---
United StatesIMUX
Immunic Inc
129.5M
-0.7x
---
United StatesANVS
Annovis Bio Inc
128.1M
-1.9x
---
United StatesVTGN
Vistagen Therapeutics Inc
132.2M
-1.4x
---
United StatesCTXR
Citius Pharmaceuticals Inc
125.3M
-3.1x
---
United StatesNVCT
Nuvectis Pharma Inc
124.7M
-4.9x
---
As of 2024-04-14

Company Information

Vor Biopharma Inc. is a clinical-stage cell and genome engineering therapy company. The Company is engaged in combining a novel patient engineering approach with targeted therapies to provide solutions for patients suffering from hematological malignancies. Its proprietary platform leverages expertise in hematopoietic stem cell (HSC) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. The Company’s lead engineered hematopoietic stem cells (eHSC) product candidate include tremtelectogene empogeditemcel (trem-cel), for the treatment for acute myeloid leukemia (AML) and other blood cancers. It is designed to replace the standard of care in transplant settings for patients suffering from acute myeloid leukemia (AML) and other blood cancers. Its VBP101 is a Phase I/II a multicenter, open-label, first-in-human study of trem-cel in patients with AML.

Contact Information

Headquarters
100 Cambridgepark Drive, Suite 101CAMBRIDGE, MA, United States 02140
Phone
617-655-6580
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
Matthew Patterson
President, Chief Executive Officer, Director
Robert Ang
Chief Financial Officer
Nathan Jorgensen
Chief Scientific Officer
Tirtha Chakraborty
Chief Medical Officer
Eyal Attar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$129.5M
Revenue (TTM)
$0.00
Shares Outstanding
68.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.75
Book Value
$2.22
P/E Ratio
-1.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.